BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9037396)

  • 1. Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat.
    Rohde DS; McKay WR; Abbadie C; Basbaum AI
    Brain Res; 1997 Jan; 745(1-2):83-95. PubMed ID: 9037396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected].
    Rohde DS; Detweiler DJ; Basbaum AI
    Neuroscience; 1996 May; 72(1):233-42. PubMed ID: 8730720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat.
    Rohde DS; Basbaum AI
    J Neurosci; 1998 Jun; 18(11):4393-402. PubMed ID: 9592116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intrathecal BAM22 on noxious stimulus-evoked c-fos expression in the rat spinal dorsal horn.
    Zeng X; Huang H; Hong Y
    Brain Res; 2004 Dec; 1028(2):170-9. PubMed ID: 15527742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN.
    Benavides M; Laorden ML; García-Borrón JC; Milanés MV
    Eur J Neurosci; 2003 Jan; 17(1):103-12. PubMed ID: 12534973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
    Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
    Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
    González-Cuello A; Milanés MV; Castells MT; Laorden ML
    Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
    Le Guen S; Gestreau C; Besson JM
    Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
    Gogas KR; Presley RW; Levine JD; Basbaum AI
    Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis.
    Le Guen S; Gestreau C; Besson JM
    J Comp Neurol; 2001 Apr; 433(2):272-96. PubMed ID: 11283964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord.
    Presley RW; Menétrey D; Levine JD; Basbaum AI
    J Neurosci; 1990 Jan; 10(1):323-35. PubMed ID: 1688935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.
    Abbadie C; Honoré P; Fournié-Zaluski MC; Roques BP; Besson JM
    Eur J Pharmacol; 1994 Jun; 258(3):215-27. PubMed ID: 8088356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation anesthetics suppress the expression of c-Fos protein evoked by noxious somatic stimulation in the deeper layer of the spinal cord in the rat.
    Hagihira S; Taenaka N; Yoshiya I
    Brain Res; 1997 Mar; 751(1):124-30. PubMed ID: 9098575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Milanés MV
    J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic modulation of noxious heat-evoked fos-like immunoreactivity in the dorsal horn of the rat sacral spinal cord.
    Jones SL
    J Comp Neurol; 1992 Nov; 325(3):435-45. PubMed ID: 1360018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla.
    Bellchambers CE; Chieng B; Keay KA; Christie MJ
    Neuroscience; 1998 Mar; 83(2):517-24. PubMed ID: 9460759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
    Murphy NP; Onaka T; Brown CH; Leng G
    Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
    Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.